Verus Capital Partners, LLC Vbi Vaccines Inc Transaction History

Verus Capital Partners, LLC

  • $1.08 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Aug 09, 2022
SELL
$1.27 - $2.47 $5,080 - $9,880
-4,000 Closed
0 $0
Q1 2020

May 26, 2020
SELL
$0.73 - $1.91 $1,460 - $3,820
-2,000 Reduced 33.33%
4,000 $4,000
Q4 2019

Feb 27, 2020
BUY
$0.48 - $1.38 $2,880 - $8,280
6,000 New
6,000 $8,000

Others Institutions Holding VBIV

# of Institutions
2
Shares Held
688K
Call Options Held
0
Put Options Held
0
View Full List

About VBI Vaccines Inc

VBIV Quotes by TradingView
  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Verus Capital Partners, LLC Portfolio

Follow Verus Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verus Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email